Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,089
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA 200a inhibits liver fibrosis of schistosoma

Ailei XuGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaView further author information
,
Guanzhen ZhongGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaView further author information
,
Jiwen WangGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaView further author information
,
Chong LiuGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaView further author information
,
Yaqian LiuGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaView further author information
&
Wei WangGastroenterology Department, Hunan Aerospace Hospital, Changsha, Hunan, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8310-3309View further author information
ORCID Icon
Pages 4736-4746 | Received 05 May 2021, Accepted 28 Jun 2021, Published online: 02 Aug 2021

References

  • Sotillo J, Doolan D, Loukas A. Recent advances in proteomic applications for schistosomiasis research: potential clinical impact. Expert Rev Proteomics. 2017;14(2):171–183.
  • Li JZ, Zhi MX, Si MD, et al. Endemic status of schistosomiasis in People’s Republic of China in 2017. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2018;30(5):481–488.
  • Song L, Wu X, Sacko M, et al. History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination. Parasitol Res. 2016;115(11):4071–4081.
  • Brandon-Warner E, Feilen NA, Culberson CR, et al. Processing of miR17-92 cluster inhepatic stellate cells promotes hepatic fibrogenesis during alcoholinduced injury. Alcohol Clin Exp Res. 2016;40(7):1430–1442.
  • Lee YS, Kim SY, Ko E, et al. Exosomes derived from palmitic acid treated hepatocytes induce fibrotic activation of hepatic stellatecells. Sci Rep. 2017;7(1):3710.
  • Gressner AM, Werskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10(1):76–99.
  • Su J, Zhang A, Shi Z, et al. Micro RNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin. Int J Oncol. 2012;40(40):1162–1170.
  • He X, Tang R, Sun Y, et al. MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis. Ebiomedicine. 2016;13:339–347.
  • Yang JJ, Tao H, Liu LP, et al. MiR-200a controls hepatic stellate cell activation and fibrosis via sirt1/notch1 signal pathway. Inflamm Res. 2017;66(4):341–352.
  • Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180(2):484–493.
  • Sun X, He Y, Ma TT, et al. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation. Mol Cell Biochem. 2014 Mar;388(1–2):11–23.
  • Hu BL, Shi C, Lei RE, et al. Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin. Sci Rep. 2016 Nov 7;6(1):36436
  • Arjmand A, Tsipouras MG, Tzallas AT, et al. Quantification of liver fibrosis—A comparative study. Appl Sci. 2020;10(2):447.
  • Ge WS, Wang YJ, Wu JX, et al. Beta-catenin is overexpressed in hepatic fibrosis and blockage of wnt/beta-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep. 2014;9(6):2145–2151.
  • Ang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180(2):484–493.
  • Herbert DR, Orekov T, Perkins C, et al. IL-10 and TGF-beta redundant lyprotect against severe liver in jury and mortality during acute schistosomiasis. J Immunol. 2008;181(10):7214–7220.
  • Chen X, Shi C, Meng X, et al. Inhibition of Wnt/β-caten in signaling suppresses bleomycin-inducedpulmonary fibrosisby attenuating the expression of TGF-β1 and FGF-2. Exp MolPathol. 2016;101:22–30.
  • Wang B. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes. 2011;60(1):280–7.
  • Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012 Feb;180(2):484–493.
  • Xu M, Wang G, Zhou H, et al. TGF-β1-miR-200a-PTEN induces epithelial-mesenchymal transition and fibrosis of pancreatic stellate cells. Mol Cell Biochem. 2017 Jul;431(1–2):161–168.
  • Li L, Ran J, Li L, et al. Gli3 is a novel downstream target of miR-200a with an anti-fibrotic role for progression of liver fibrosis in vivo and in vitro. Mol Med Rep. 2020 Apr;21(4):1861–1871.
  • Xiong M, Jiang L, Zhou Y, et al. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol. 2012 Feb 1;302(3):F369–79.
  • Yu F, Zheng Y, Hong W, et al. Micro RNA-200a suppresses epithelial-to-mesenchymal transition in rat hepatic stellate cells via GLI family zinc finger 2. Mol Med Rep. 2015 Dec;12(6):8121–8128.
  • Humphries B, Yang C. The microRNA-200 family:Small molecules with novel roles in cancer development, progression and therapy. Oncotarget. 2015;6(9):6472–6498.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.